1. Home
  2. AGEN vs EPM Comparison

AGEN vs EPM Comparison

Compare AGEN & EPM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agenus Inc.

AGEN

Agenus Inc.

HOLD

Current Price

$3.47

Market Cap

147.4M

Sector

Health Care

ML Signal

HOLD

Logo Evolution Petroleum Corporation Inc.

EPM

Evolution Petroleum Corporation Inc.

HOLD

Current Price

$4.64

Market Cap

165.9M

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGEN
EPM
Founded
1994
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
147.4M
165.9M
IPO Year
1999
1996

Fundamental Metrics

Financial Performance
Metric
AGEN
EPM
Price
$3.47
$4.64
Analyst Decision
Buy
Strong Buy
Analyst Count
2
3
Target Price
$14.50
$4.83
AVG Volume (30 Days)
889.8K
389.3K
Earning Date
05-12-2026
05-05-2026
Dividend Yield
N/A
10.08%
EPS Growth
100.00
N/A
EPS
1.02
N/A
Revenue
$42,877,086.00
$43,229,621.00
Revenue This Year
$107.63
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$3.48
N/A
Revenue Growth
89.95
N/A
52 Week Low
$2.71
$3.19
52 Week High
$7.34
$5.70

Technical Indicators

Market Signals
Indicator
AGEN
EPM
Relative Strength Index (RSI) 42.93 50.62
Support Level $2.91 $4.38
Resistance Level $4.72 $4.63
Average True Range (ATR) 0.25 0.16
MACD -0.07 -0.03
Stochastic Oscillator 24.30 53.80

Price Performance

Historical Comparison
AGEN
EPM

About AGEN Agenus Inc.

Agenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases. Its primary business is immuno-oncology (I-O), where it advances antibody-based programs designed to activate innate and adaptive immunity, overcome tumor immune evasion, and expand the number of patients who may benefit from immunotherapy. The Company's clinical program includes botensilimab (BOT or AGEN1181), both as a monotherapy and in combination with balstilimab (BAL), alongside a portfolio of other clinical-stage immuno-oncology assets that may be used independently or in combination therapies. The Company operates in the United States, which contributes the majority of its revenue, as well as in other international markets.

About EPM Evolution Petroleum Corporation Inc.

Evolution Petroleum Corp is an independent energy company focused on owning and investing in onshore oil and natural gas properties across the United States. Its portfolio includes non-operated interests in various production fields such as CO2 enhanced oil recovery in Louisiana, secondary recovery production in Wyoming, and shale gas reservoirs in Texas and North Dakota. The company generates revenue from the production and sale of oil and natural gas, leveraging specialized technologies to extend reservoir life and enhance recoveries.

Share on Social Networks: